John Biedenbach, NP
Family · Caldwell, OHNPI 1174878979
Payments from drug & device makers
Across 135 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$662
- AbbVie$254
- Novo Nordisk$219
- Boehringer Ingelheim$163
- Pfizer$153
- Merck$144
- plus $617 from 14 others
What the payments were for
- Food & beverage$2,206100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 41 | $662 |
| AbbVie | 13 | $254 |
| Novo Nordisk | 13 | $219 |
| Boehringer Ingelheim | 11 | $163 |
| Pfizer | 9 | $153 |
| Merck | 10 | $144 |
| Lilly USA, LLC | 8 | $120 |
| Daiichi Sankyo Inc. | 6 | $98 |
| Dexcom, Inc. | 3 | $55 |
| Johnson & Johnson | 4 | $52 |
| Currax Pharmaceuticals LLC | 3 | $46 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $40 |
| Vertex | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Exact Sciences | 1 | $24 |
| Amgen | 1 | $23 |
| GSK | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $13 |
How this compares
$2,211 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 85 | $101,503 |
| FarxigaDapagliflozin Propanediol | 86 | $82,679 |
| JardianceEmpagliflozin | 87 | $79,116 |
| EliquisApixaban | 76 | $66,901 |
| OzempicSemaglutide | 42 | $39,785 |
| XareltoRivaroxaban | 41 | $33,347 |
| MounjaroTirzepatide | 23 | $32,602 |
| RybelsusSemaglutide | 11 | $21,435 |
| JanuviaSitagliptin Phosphate | 15 | $19,668 |
| Spiriva RespimatTiotropium Bromide | 13 | $10,310 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 31 | $10,139 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,211 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $8,009 |
| Spiriva HandihalerTiotropium Bromide | 13 | $6,626 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 193 | $5,134 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $120 | $134,104108 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $163 | $89,426100 claims |
| AstraZenecaFarxiga | $662 | $82,67986 claims |
| PfizerEliquis | $153 | $66,90176 claims |
| Novo NordiskOzempic, Rybelsus | $219 | $61,22153 claims |
| Johnson & JohnsonXarelto | $52 | $33,34741 claims |
| MerckJanuvia | $144 | $19,66815 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $22 | $12,28824 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,812 family providers in Ohio.
Other family in Caldwell
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.